{
  "company": {
    "name": "Diagonal Therapeutics",
    "website": "https://diagonaltx.com/",
    "record": "https://startuphistory.org/c/diagonaltx.com"
  },
  "status": null,
  "history_since": "2024-04-04T16:08:17.000Z",
  "baseline": {
    "snapshot_id": "70ed6d6a9dfd45851cfcd48559a9d857dd57b0477b69c4cf59d9a6059978a4dd",
    "observed_at": "2024-04-04T16:08:17.000Z",
    "headline": "ADVANCING A GROUND-BREAKING APPROACH TO AGONIST ANTIBODY THERAPEUTICS",
    "description": "Diagonal Therapeutics pioneers a new era in medicine by advancing agonist antibody therapeutics targeting the root causes of devastating diseases. Discover our ground-breaking approach to reactivate c",
    "evidence": "https://web.archive.org/web/20240404160817/https://www.diagonaltx.com/",
    "evidence_kind": "internet_archive",
    "facts": {
      "version": 1,
      "pages": [
        {
          "page": "home",
          "customers": [],
          "investors": [
            "Dana-Farber",
            "Illumina Ventures",
            "Lilly Asia Ventures",
            "5am Ventures",
            "Bristol Myers Squibb",
            "OUP",
            "Qatar Investment Authority"
          ],
          "prices": [],
          "compliance": [],
          "funding": []
        }
      ]
    },
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T13:27:50.181Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2025-07-10T16:46:36.000Z",
      "variants": [
        {
          "headline": "ADVANCING A GROUND-BREAKING APPROACH TO AGONIST ANTIBODY THERAPEUTICS",
          "subhead": "Diagonal Therapeutics pioneers a new era in medicine by advancing agonist antibody therapeutics targeting the root causes of devastating diseases. Discover our ground-breaking approach to reactivate c",
          "observed_at": "2024-04-04T16:08:17.000Z",
          "evidence": "https://web.archive.org/web/20240404160817/https://www.diagonaltx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "ADVANCING A GROUND-BREAKING APPROACH TO AGONIST ANTIBODY THERAPEUTICS",
          "subhead": "Diagonal Therapeutics pioneers a new era in medicine by advancing agonist antibody therapeutics targeting the root causes of devastating diseases. Discover our ground-breaking approach to reactivate c",
          "observed_at": "2024-09-12T16:08:23.000Z",
          "evidence": "https://web.archive.org/web/20240912160823/https://www.diagonaltx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "ADVANCING A GROUND-BREAKING APPROACH TO AGONIST ANTIBODY THERAPEUTICS",
          "subhead": "Diagonal Therapeutics pioneers a new era in medicine by advancing agonist antibody therapeutics targeting the root causes of devastating diseases. Discover our ground-breaking approach to reactivate c",
          "observed_at": "2025-01-13T20:03:53.000Z",
          "evidence": "https://web.archive.org/web/20250113200353/https://www.diagonaltx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "ADVANCING A GROUND-BREAKING APPROACH TO DISEASE-MODIFYING CLUSTERING ANTIBODY THERAPEUTICS",
          "subhead": "Diagonal Therapeutics pioneers a new era in medicine by advancing agonist antibody therapeutics targeting the root causes of devastating diseases. Discover our ground-breaking approach to reactivate c",
          "observed_at": "2025-07-10T13:15:24.000Z",
          "evidence": "https://web.archive.org/web/20250710131524/https://www.diagonaltx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "ADVANCING A GROUND-BREAKING APPROACH TO DISEASE-MODIFYING CLUSTERING ANTIBODY THERAPEUTICS",
          "subhead": "Diagonal Therapeutics pioneers a new era in medicine by advancing agonist antibody therapeutics targeting the root causes of devastating diseases. Discover our ground-breaking approach to reactivate c",
          "observed_at": "2025-07-10T16:46:36.000Z",
          "evidence": "https://web.archive.org/web/20250710164636/https://www.diagonaltx.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "ADVANCING A GROUND-BREAKING APPROACH TO DISEASE-MODIFYING CLUSTERING ANTIBODY THERAPEUTICS",
      "subhead": "Diagonal Therapeutics pioneers a new era in medicine by advancing agonist antibody therapeutics targeting the root causes of devastating diseases. Discover our ground-breaking approach to reactivate c",
      "from": "2024-04-04T16:08:17.000Z",
      "to": "2025-07-10T16:46:36.000Z",
      "captures": 5,
      "evidence": "https://web.archive.org/web/20250710164636/https://www.diagonaltx.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2024-04-04T16:08:17.000Z",
          "to": "2025-07-10T16:46:36.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-05T13:27:50.181Z",
      "variants": [
        {
          "headline": "Advancing clustering antibodies to correct the root cause of genetic diseases",
          "subhead": "Diagonal Therapeutics pioneers a new era in medicine by advancing clustering antibody therapeutics targeting the root causes of devastating diseases.",
          "observed_at": "2026-01-08T16:54:35.000Z",
          "evidence": "https://web.archive.org/web/20260108165435/https://diagonaltx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Advancing clustering antibodies to correct the root cause of genetic diseases",
          "subhead": "Diagonal Therapeutics pioneers a new era in medicine by advancing clustering antibody therapeutics targeting the root causes of devastating diseases.",
          "observed_at": "2026-01-23T02:03:50.000Z",
          "evidence": "https://web.archive.org/web/20260123020350/https://diagonaltx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Advancing clustering antibodies to correct the root cause of genetic diseases",
          "subhead": "Diagonal Therapeutics pioneers a new era in medicine by advancing clustering antibody therapeutics targeting the root causes of devastating diseases.",
          "observed_at": "2026-05-17T13:59:06.000Z",
          "evidence": "https://web.archive.org/web/20260517135906/https://diagonaltx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Advancing clustering antibodies to correct the root cause of genetic diseases",
          "subhead": "Diagonal Therapeutics pioneers a new era in medicine by advancing clustering antibody therapeutics targeting the root causes of devastating diseases.",
          "observed_at": "2026-11-05T13:27:50.181Z",
          "evidence": "https://diagonaltx.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Advancing clustering antibodies to correct the root cause of genetic diseases",
      "subhead": "Diagonal Therapeutics pioneers a new era in medicine by advancing clustering antibody therapeutics targeting the root causes of devastating diseases.",
      "from": "2026-01-08T16:54:35.000Z",
      "to": "2026-11-05T13:27:50.181Z",
      "captures": 4,
      "evidence": "https://diagonaltx.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2026-01-08T16:54:35.000Z",
          "to": "2026-11-05T13:27:50.181Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-d060a226615689e9a30a333620fa2760b2688b04aeff132a4c498a76564b8a4c:31312488ba01d5ea10e9a4fe59acbb6499386b2b11ce8f3da1098ae0ccb3f2ec:headline:c639dd1b8e6412ce",
      "before_evidence": "https://web.archive.org/web/20250710164636/https://www.diagonaltx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “ADVANCING A GROUND-BREAKING APPROACH TO DISEASE-MODIFYING CLUSTERING ANTIBODY THERAPEUTICS” to “Advancing clustering antibodies to correct the root cause of genetic diseases”.",
      "between": {
        "from": "2025-07-10T16:46:36.000Z",
        "to": "2026-01-08T16:54:35.000Z"
      },
      "evidence": "https://web.archive.org/web/20260108165435/https://diagonaltx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 2,
      "id": "page-8f3492fb977e74de4c4811d7c5f2f32b0be077d649b98764aefe5baba7232afd:ee6eaf52145f4eb414f1baabebdb067767c6927b7110264038796c89d0416e80:investors:1f61da347b0715a4",
      "before_evidence": "https://web.archive.org/web/20260123020350/https://diagonaltx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "investors",
      "label": "Investors",
      "summary": "Now shows investor logos: Headshot of John Lee, Headshot of Patrick Andre, Headshot of Ruhi Ahmed and Jonathan Piazza Headshot.",
      "between": {
        "from": "2026-01-23T02:03:50.000Z",
        "to": "2026-05-17T13:59:06.000Z"
      },
      "evidence": "https://web.archive.org/web/20260517135906/https://diagonaltx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-investor-logos"
    }
  ],
  "update": {
    "headline": "Diagonal Therapeutics updates homepage messaging and investor section",
    "summary": "Diagonal Therapeutics revised its homepage headline about clustering antibodies for genetic diseases and now shows several named investor headshots on its site. These updates may reflect clarified positioning and a choice to highlight identified individual backers.",
    "points": [
      {
        "text": "Between July 2025 and January 2026, Diagonal Therapeutics changed its homepage headline to “Advancing clustering antibodies to correct the root cause of genetic diseases”.",
        "kind": "fact",
        "changes": [
          1
        ]
      },
      {
        "text": "Between January 2026 and May 2026, the company began showing investor headshots for John Lee, Patrick Andre, Ruhi Ahmed and Jonathan Piazza.",
        "kind": "fact",
        "changes": [
          2
        ]
      },
      {
        "text": "This updated headline suggests an emphasis on clustering antibodies aimed at underlying causes of genetic diseases.",
        "kind": "interpretation",
        "changes": [
          1
        ]
      },
      {
        "text": "The addition of named investor headshots is consistent with Diagonal Therapeutics choosing to highlight specific individual backers on its site.",
        "kind": "interpretation",
        "changes": [
          2
        ]
      }
    ],
    "written_at": "2026-11-07T21:03:59.657Z",
    "basis": "ai_analysis",
    "model": "gpt-5.1-2025-11-13"
  },
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Diagonal Therapeutics” company record, https://startuphistory.org/c/diagonaltx.com"
}